ALC vs BGT

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

ALC

ALCIDION FPO [ALC]

54MEDIUM

BGT

BIOGENETEC FPO [BGT]

54MEDIUM

Score Breakdown

ALC BGT
Technical
64
68
Catalyst
50
51
Sentiment
50
50
Fundamental
87
41
Momentum
72
80
Risk Gate
50
34

Key Metrics

ALC Metric BGT
$137.0MMarket Cap$10.7M
1.4MAvg Volume (20d)128K
N/AShort InterestN/A
$0.14552-Week High$0.061
$0.06152-Week Low$0.016
+5.0%Daily Change+0.0%
$0.105Entry Price$0.035
+4.4%ROE-202.2%
+8.0%Profit MarginN/A

Active Signals

ALC Signals

●MACD momentum is picking up steam
●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (2.8x)
●Strong revenue growth (+44%)
●Piotroski F-Score strong (7/9, low-confidence approx)

BGT Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.7 quarters)
●Strong revenue growth (+208%)
●Micro-cap ($5-20M) - high risk
●CANSLIM S: Tight float (35%)
●Not enough chatter to gauge sentiment — defaulting to neutral

Ask Scout AI to compare ALC and BGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ALC Full Analysis → BGT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).